Spenser Hughes1, Lisa M Jaremka2, Catherine M Alfano3, Ronald Glaser4, Stephen P Povoski5, Adele M Lipari5, Doreen M Agnese5, William B Farrar5, Lisa D Yee5, William E Carson5, William B Malarkey6, Janice K Kiecolt-Glaser7. 1. Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Department of Psychology, The Ohio State University, Columbus, OH 43210, USA. Electronic address: Spenser.Hughes@osumc.edu. 2. Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH 43210, USA. 3. National Cancer Institute, Bethesda, MD 20892, USA. 4. Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH 43210, USA. 5. Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Department of Surgery, The Ohio State University College of Medicine, Columbus, OH 43210, USA. 6. Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH 43210, USA. 7. Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Department of Psychology, The Ohio State University, Columbus, OH 43210, USA; Department of Psychiatry, The Ohio State University College of Medicine, Columbus, OH 43210, USA; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Abstract
OBJECTIVE: Pain and depressive symptoms are commonly experienced by cancer survivors. Lower social support is linked to a variety of negative mental and physical health outcomes among survivors. Immune dysregulation may be one mechanism linking low social support to the development of pain and depressive symptoms over time. Accordingly, the goal of the present study was to examine the relationships among survivors' social support, pain, depressive symptoms, and inflammation. METHODS: Breast cancer survivors (N=164, stages 0-IIIA) completed two study visits, one before any cancer treatment and the other 6 months after the completion of surgery, radiation, or chemotherapy, whichever came last. Women completed self-report questionnaires assessing social support, pain, and depressive symptoms, and provided a blood sample at both visits. RESULTS: Survivors with lower social support prior to treatment experienced higher levels of pain and depressive symptoms over time than their more socially supported counterparts. Furthermore, women with lower pretreatment social support had higher levels of IL-6 over time, and these elevations in IL-6 predicted marginally larger increases in depressive symptoms. CONCLUSIONS: The results of this study suggest that social support at the time of diagnosis predicts the post-treatment development of pain, depressive symptoms, and inflammation. Consequently, early interventions targeting survivors' social networks could improve quality of life during survivorship.
OBJECTIVE:Pain and depressive symptoms are commonly experienced by cancer survivors. Lower social support is linked to a variety of negative mental and physical health outcomes among survivors. Immune dysregulation may be one mechanism linking low social support to the development of pain and depressive symptoms over time. Accordingly, the goal of the present study was to examine the relationships among survivors' social support, pain, depressive symptoms, and inflammation. METHODS:Breast cancer survivors (N=164, stages 0-IIIA) completed two study visits, one before any cancer treatment and the other 6 months after the completion of surgery, radiation, or chemotherapy, whichever came last. Women completed self-report questionnaires assessing social support, pain, and depressive symptoms, and provided a blood sample at both visits. RESULTS: Survivors with lower social support prior to treatment experienced higher levels of pain and depressive symptoms over time than their more socially supported counterparts. Furthermore, women with lower pretreatment social support had higher levels of IL-6 over time, and these elevations in IL-6 predicted marginally larger increases in depressive symptoms. CONCLUSIONS: The results of this study suggest that social support at the time of diagnosis predicts the post-treatment development of pain, depressive symptoms, and inflammation. Consequently, early interventions targeting survivors' social networks could improve quality of life during survivorship.
Authors: Pamela H Mitchell; Lynda Powell; James Blumenthal; Jennifer Norten; Gail Ironson; Carol Rogers Pitula; Erika Sivarajan Froelicher; Susan Czajkowski; Marston Youngblood; Marc Huber; Lisa F Berkman Journal: J Cardiopulm Rehabil Date: 2003 Nov-Dec Impact factor: 2.081
Authors: Candyce H Kroenke; Laura D Kubzansky; Eva S Schernhammer; Michelle D Holmes; Ichiro Kawachi Journal: J Clin Oncol Date: 2006-03-01 Impact factor: 44.544
Authors: Bruce A Arnow; Enid M Hunkeler; Christine M Blasey; Janelle Lee; Michael J Constantino; Bruce Fireman; Helena C Kraemer; Robin Dea; Rebecca Robinson; Chris Hayward Journal: Psychosom Med Date: 2006 Mar-Apr Impact factor: 4.312
Authors: Heather M Derry; Avelina C Padin; Jennifer L Kuo; Spenser Hughes; Janice K Kiecolt-Glaser Journal: Curr Psychiatry Rep Date: 2015-10 Impact factor: 5.285
Authors: Z Khazaeipour; E Ahmadipour; V Rahimi-Movaghar; F Ahmadipour; A R Vaccaro; B Babakhani Journal: Spinal Cord Date: 2016-12-06 Impact factor: 2.772
Authors: Yijun Bao; Lizhuo Li; Yanlei Guan; Yan Liu; Wei Wang; Dan Zhao; Shanwei Tao; Yuhui Ling; Yan Wang; Bo Bi; Anhua Wu; Liu Cao Journal: Support Care Cancer Date: 2018-06-25 Impact factor: 3.603
Authors: William H Walker; O Hecmarie Meléndez-Fernández; Jordan L Pascoe; Ning Zhang; A Courtney DeVries Journal: Brain Behav Immun Date: 2020-07-29 Impact factor: 7.217
Authors: Devika R Jutagir; Bonnie B Blomberg; Charles S Carver; Suzanne C Lechner; Kiara R Timpano; Laura C Bouchard; Lisa M Gudenkauf; Jamie M Jacobs; Alain Diaz; Susan K Lutgendorf; Steve W Cole; Aaron S Heller; Michael H Antoni Journal: Breast Cancer Res Treat Date: 2017-05-30 Impact factor: 4.872